Vaccines For Immune Mediated Diseases

Patients with safe interceded incendiary ailments (IMID, for example, RA, IBD or psoriasis, are at augmented danger of contamination, in part in light of the malady itself, however for the most part in light of treatment with immunomodulatory or immunosuppressive medications. Regardless of their raised hazard for immunization preventable ailment, inoculation scope in IMID patients is shockingly low.

 

  • Central nervous system-targeted & Tissue-specific autoimmunity
  • Innate immunity and diabetes vaccines
  • Vaccination strategy in patients with IMID
  • Vaccine safety: impact on disease activity in IMID patients
  • Vaccines for autoimmune skin disorders & neuropathies
  • Vaccines for immunodeficiency diseases

Related Conference of Vaccines For Immune Mediated Diseases

August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland, New Zealand
October 14-15, 2019

2nd International Conference on Vaccine Research

Paris, France
October 25-26, 2019

37thVaccination, Immunization & Antibiotics

Vancouver, Canada
November 12-13, 2019

35th World Vaccines & Immunization Congress

Brisbane, Australia
November 21-22, 2019

International conference on Vaccine and Vaccine research

Berlin,Germany

Vaccines For Immune Mediated Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in